Part of the IMF Patient Education Tools Series
Preventing Peripheral Neuropathy From Novel Agents for Multiple Myeloma
Patient Education Sheet: Preventing Peripheral Neuropathy From Novel Agents for Multiple Myeloma
KEY POINTS
symptoms you should monitor and report to your healthcare
provider are as follows.
Peripheral neuropathy is a change in feeling in the arms,
hands, fingers, legs, feet, toes, or other body parts. It can
­
be a symptom of multiple myeloma or related to the use of
­
medications to treat myeloma, such as novel therapies tha-
­
lidomide and bortezomib. Managing peripheral neuropathy
can reduce pain and other symptoms and can allow you to
­
receive the best treatment for your myeloma. Your healthcare
­ Difficulty opening jars or feeling the shape of small
provider may change your dose or medication schedule to
objects in your hand
help manage your symptoms.
­
SYMPTOMS OF PERIPHERAL NEUROPATHY
MANAGING THE SYMPTOMS
You may have the following symptoms in toes and feet, fin-
gers and hands, or lips.
If symptoms become more severe, your healthcare provider
may recommend the following.
Always report symptoms early to your healthcare team.
You may have an examination before treatment and at vari-
ous times during treatment to see whether you have any
-
you to move more easily and safely, carry out your daily ac-
ropathy affects your daily activities.
tivities, and prevent unnecessary pain and discomfort.
Note.
Myeloma Manager Personal Care Assistant
Note.
Reprint · June 2008 · Supplement to Volume 12, Number 3 · Clinical Journal of Oncology Nursing

---